Advertisement

Topics

PubMed Journals Articles About "Late John Mendlein Joins Reinventing Biotech Lineup April" RSS

04:46 EDT 24th July 2016 | BioPortfolio

Late John Mendlein Joins Reinventing Biotech Lineup April PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Late John Mendlein Joins Reinventing Biotech Lineup April articles that have been published worldwide.

More Information about "Late John Mendlein Joins Reinventing Biotech Lineup April" on BioPortfolio

We have published hundreds of Late John Mendlein Joins Reinventing Biotech Lineup April news stories on BioPortfolio along with dozens of Late John Mendlein Joins Reinventing Biotech Lineup April Clinical Trials and PubMed Articles about Late John Mendlein Joins Reinventing Biotech Lineup April for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Late John Mendlein Joins Reinventing Biotech Lineup April Companies in our database. You can also find out about relevant Late John Mendlein Joins Reinventing Biotech Lineup April Drugs and Medications on this site too.

Showing "Late John Mendlein Joins Reinventing Biotech Lineup April" PubMed Articles 1–25 of 3,000+

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015. The focus was once again on fostering collaboration between neuro-oncologist, neurosurgeons, scientists, leaders from biotechnology and pharmaceutical industries, and members of the financial community. The summit highlighted the recent advances in the treatment of brain tumor, and specifically focused on tar...


A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells.

B cells may have a negative regulatory role, mainly mediated by interleukin 10 (IL-10). We recently showed that regulatory B-cell functions are impaired in patients with rheumatoid arthritis (RA) and that mice transgenic for a proliferation-inducing ligand (APRIL) are protected against collagen-induced arthritis. We aimed to explore the effect of APRIL on human B-cell IL-10 production, in healthy subjects and in patients with RA. The IL-10 production of B-cell was greater with APRIL than with BLyS or contro...

Chronic myeloid leukemia: reminiscences and dreams.

With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the cytogenetic anatomy of the Philadelphia chromosome, which subsequently led to the identification of the BCR-ABL1 fusion gene and its principal pathogenetic role in the development of chronic myeloid leukemia. This work was also of major importance to support the idea that cytogenetic changes were drivers of leukemogenesis. John Goldman ...


Reinventing nonpatent literature for pharmaceutical patenting.

The Novel New Jersey Eyewitness Instruction Induces Skepticism but Not Sensitivity.

In recent decades, social scientists have shown that the reliability of eyewitness identifications is much worse than laypersons tend to believe. Although courts have only recently begun to react to this evidence, the New Jersey judiciary has reformed its jury instructions to notify jurors about the frailties of human memory, the potential for lineup administrators to nudge witnesses towards suspects that they police have already identified, and the advantages of alternative lineup procedures, including bli...

The Clearer BENEFITS of Belatacept.

"In the long run," the economist John Maynard Keynes wryly observed in his 1923 A Tract on Monetary Reform, "we are all dead." Given the logistic barriers to performing long-term studies of immunosuppression in kidney-transplant recipients, as well as the associated expense, many transplant professionals are similarly pessimistic about how to determine adequate long-term regimens in the current era, in which short-term results are excellent but late transplant loss remains a vexing problem. More than 14,000...

Bayer joins CRISPR.

Erratum: When biotech goes bad.

First-quarter biotech job picture.

1Q16-the biotech bear growls.

Fourth-quarter biotech job picture.

Fresh from the biotech pipeline-2015.

2015-another banner year for biotech.

Public biotech in 2015 - the numbers.

Trade-sale exits in different biotech sectors.

A face-lift for biotech rules begins.

How China can enhance adoption of biotech crops.

Reflection for Nursing Life: Principles, Process and Practice McKinnon John Reflection for Nursing Life: Principles, Process and Practice 138pp £25.99 Routledge 9781138757599 1138787590 Formula: see text.

Reflection is a key part of life as a nurse, and even more so since the Nursing and Midwifery Council introduced the revalidation process in April.

IBM debuts hyped 'cognitive cloud' biotech HQ in Cambridge.

Biotech's wellspring-a survey of the health of the private sector in 2015.

Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes.

Diabetes mellitus is a chronic disease that affects over 382 million people worldwide. Type-1 Diabetes (T1D) is classified as an autoimmune disease that results from pancreatic β-cell destruction and insulin deficiency. Type-2 Diabetes (T2D) is characterized principally by insulin resistance in target tissues followed by decreased insulin production due to β-cell failure. It is challenging to identify immunological markers such as inflammatory molecules that are triggered in response to changes during the...

There and Back Again: Mitchell Finer on the Journey of Biotech from Start-Up to Success.

Phosphoinositide regulation of TRPM channels - TRPM3 joins the club!

Brainstem auditory evoked potentials in late preterm infants at term-equivalent age.

To detect differences between late preterm and term infants in the brainstem auditory evoked response (BAER) variables that predispose to neurodevelopmental abnormalities, 36 late preterm infants and 87 term infants were recruited. Data collected with the click level at 70 dB nHL were used for analysis. The latencies of waves I (2.74±0.20 msec vs. 2.74±0.42 msec), III (5.55±0.33 msec vs. 5.53±0.45 msec) and V (7.55±0.34 msec vs. 7.59±0.44 msec), and the interpeak intervals for late preterm infants wer...

Late, Late-Onset Group B Streptococcus Cellulitis With Bacteremia.

Group B streptococcus (GBS) infection remains a leading cause of serious neonatal and early infantile infection. As the infection often presents with nonspecific symptoms, and is associated with underlying bacteremia, prompt investigation and treatment is required. We report a case of late, late-onset GBS infection with bacteremia in a 94-day-old boy experiencing cellulitis of the left hand. Although late-onset disease or late, late-onset disease has been reported to be common among infants with underlying ...


Quick Search
Advertisement